The 2012 US Infectious Disease Testing Market
This report presents a comprehensive analysis of the US infectious disease testing market, including:
Contains 1,037 pages and 177 tables
- Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms.
- Ten-year test volume and sales forecasts for nearly 80 infectious disease testing performed in US hospitals, blood banks, physician offices, public health and commercial laboratories.
- Instrumentation technologies and feature comparison of leading analyzers.
- Sales and market shares of leading suppliers.
- Emerging diagnostic technologies and their potential market applications.
- Product development opportunities.
- Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
- Business opportunities and strategic recommendations for suppliers.
Contains 1,037 pages and 177 tables
INTRODUCTION
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Infectious Disease Tests
1. AIDS
a. Background
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. Aeromonas
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Anthrax/Bacillus Anthracis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Arboviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Babesiosis
a. Background
7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Blastocystis Hominis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. Brucella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. Campylobacter
a. Background
b. Diagnostic Tests
11. Candida
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. Chagas Disease
a. Background
13. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. Chlamydia
a. Background
c. Vaccines and Drugs
15. Clostridium Difficile
a. Background
16. Coronaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. Coxsackieviruses
a. Background
c. Vaccines and Drugs
18. Creutzfeldt-Jakob’s Disease
a. Background
19. Cryptosporidium Parvum
a. Background
b. Diagnostic Tests
20. Cyclospora Cayetanensis
a. Background
c. Vaccines and Drugs
21. Cytomegalovirus
a. Background
c. Vaccines and Drugs
22. Ebola Virus
a. Background
c. Vaccines and Drugs
23. E. Coli
a. Background
c. Vaccines and Drugs
24. EchoVirus
a. Background
c. Vaccines and Drugs
25. Encephalitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
26. Enteroviruses
a. Background
b. Diagnostic Tests
27. Epstein-Barr Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
28. Giardia Lamblia
a. Background
c. Vaccines and Drugs
29. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
30. Granuloma Inguinale
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
31. Hantavirus
a. Background
32. Helicobacter Pylori
a. Background
c. Vaccines and Drugs
a. Background
b. Hepatitis A
c. Hepatitis B
d. Hepatitis C
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
35. Human Herpes Virus-6 (HHV-6)
a. Background
c. Vaccines and Drugs
36. Influenza Viruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
37. Legionella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
38. Lyme Disease
a. Background
c. Vaccines and Drugs
39. Lymphogranuloma Venereum (LGV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
40. Malaria
a. Background
b. Diagnostic Tests
41. Measles (Rubeola)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
42. Meningitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
a. Background
44. Mononucleosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
45. Mumps
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
a. Background
c. Vaccines and Drugs
47. Papillomaviruses
a. Background
c. Vaccines and Drugs
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
49. Pneumonia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
50. Polyomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
51. Pseudomonas Aeruginosa
a. Background
c. Vaccines and Drugs
52. Rabies
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
53. Respiratory Syncytial Virus (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
54. RhinoViruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
55. RotaVirus (REOVIRUS)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5 6. Rubella(MEASLES)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
58. Septicemia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
59. Shigellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
60. Staphylococcus Aureus
a. Background
c. Vaccines and Drugs
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
a. Background
b. Diagnostic Tests
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
64. Trichomonas Vaginalis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
65. Tuberculosis
a. Background
b. Diagnostic Tests
66. Vibrio
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
67. West Nile Virus
a. Background
c. Vaccines and Drugs
68. Yersina
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review and Market Needs
1. DNA Probes
a. Technology Overview
b. Amplification Methods
3. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
f. Immunoprecipitation
4. Differential Light Scattering
5. Microcomputers and Automation
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. MRI
11. Gel Microdroplets
12. Other
D. Personal Testing
E. Worldwide Business Environment
F. Worldwide Market Structure
G. Worldwide Market Size and Growth
U.S.A.
A. Executive Summary
B. Business Environment
1. Health Care Expenditures
2. Cost Consciousness
3. Reimbursement
4. Industry Consolidation
5. Managed Care
a. HMO
b. PPO
6. Hospitals
7. Admissions
8. Length of Stay
9. Industry Diversification
10. Physician Demographics
11. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
12. Laboratory Regulations
13. FDA Reform
C. Market Structure
1. Centralized Testing
a. Hospitals
b. Commercial/Private Laboratories
c. Blood Banks
1) Community and Regional Centers
2) Plasma Fractionation Centers
2. Decentralized Testing
a. Physician Offices/Group Practices
b. Point of Care Testing
c. Other Decentralized Testing Locations
D. Market Size, Growth and Major Suppliers
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Computers, Software and Automation
D. Auxiliary Products
DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Infectious Disease Tests
1. AIDS
a. Background
- Structure and Composition
- Classification
- Origin of AIDS
- Animal Lentivirus Systems
- Virus Receptos
- HIV Infections in Humans
- Pathogenesis & Pathology: Overview of HIV Infection Course
- CD4T Lymphocytes and Memory Cells
- Monocytes and Macrophages
- Lymphoid Organs
- Neural Cells
- Viral Coinfections
- Clinical Findings
- Plasma Viral Load
- Pediatric AIDS
- Neurologic Disease
- Opportunistic Infections
- Cancer
- Immunity
- Virus Isolation
- Serology
- Detection of Viral Nucleic Acid and Antigens
- Infectivity
- Epidemiology
- Worldwide Spread of AIDS
- United States
- Routes of Transmission
- Laboratory Diagnosis
- Enzyme Immunoassay Interpretation
- Specific, Sensitivity, and Predictive Value of Enzyme Immunoassays
- Competition Assays
- Western Blot Technique
- Immuno-Fluorescence Assay (IFA)
- Radioimmunoprecipitation
- HIV-1/HIV-2 Combination Testing
- Methods of HIV-Antigen Detection
- Antigen Assays and Blood Screening
- Urine Tests
- Immunopathogenic Mechanism of HIV Infection
- DNA Probes
- Overview
- Quantitative Polymerase Chain Reaction
- In Situ PCR
- Needed Improvements
- Viral Load/Drug Resistance Testing
- Genotype and Phenotype Testing
- Blood Banking Consideration
- Antiviral Drugs
- Vaccines Against HIV
- Transmission of HIV in Blood Products
- HIV Transmission in Transplant and Artificial Insemination Recipients
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. Aeromonas
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Anthrax/Bacillus Anthracis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Arboviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Babesiosis
a. Background
7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Blastocystis Hominis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. Brucella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. Campylobacter
a. Background
b. Diagnostic Tests
- Identification from Culture
11. Candida
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. Chagas Disease
a. Background
13. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. Chlamydia
a. Background
- Chlamydia Psittaci
- Chlamydia Pneumoniae
- Chlamydia Trachomatis
c. Vaccines and Drugs
15. Clostridium Difficile
a. Background
- Pediatric Infections
- Epidemiology
- Counterimmunoelectrophoresis
- Fluorescent-Antibody Assays
- Poloymerase Chain Reactions
16. Coronaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. Coxsackieviruses
a. Background
- Herpangina
- Hand-foot-and-mouth syndrome
- Hepidemic Conjuctivitis
- Pharingitis
- Epidemic Pleurodynia
- Myodarditis,Pericarditis
- Overwhelming Infection of the Newborn
- Acute Aseptic Meningitis
- Undifferentiated Febrile Illness
- Fever with upper respiratory infection
- Encephalitis
- Asymptomatic Infection
c. Vaccines and Drugs
18. Creutzfeldt-Jakob’s Disease
a. Background
- Blood Transmission
- Major Commercial and Academic Players
- Bayer
- Disease Sciences/Bio Tec Global
- Imperial College of Medicine
- Ortho-Clinical Diagnostics
- Pall
- ProMetic Life Sciences
- Proteome Sciences/Idexx
- Q-One Biotech
- Serono
- U.S. Agricultural Research Service
19. Cryptosporidium Parvum
a. Background
b. Diagnostic Tests
- Histologic
- Laboratory Parasitology
- Serodiagnosis
20. Cyclospora Cayetanensis
a. Background
- Asymptomatic Infection
- Diarrhea in Immunocompetent Persons
- Diarrhea in Immunocompromisedersons
c. Vaccines and Drugs
21. Cytomegalovirus
a. Background
- Chorioretinitis
- Gastrointestinal
- Central Nervous System Disease
c. Vaccines and Drugs
22. Ebola Virus
a. Background
- Epidemiology
- Hemorrhagic Fever
c. Vaccines and Drugs
23. E. Coli
a. Background
- Role of Escherichia Coli in Causing Diarrhea
- EPEC
- ETEC
- EIEC
- EHEC
c. Vaccines and Drugs
24. EchoVirus
a. Background
- Acute Aseptic Miningitisis
- Encephalitis
- Exanthems
- Respiratory Disease
- Myope;ricarditis
- Neonatal Infections
c. Vaccines and Drugs
25. Encephalitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
26. Enteroviruses
a. Background
b. Diagnostic Tests
- Viral Isolation and Identification
- Antibody Tests
27. Epstein-Barr Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
28. Giardia Lamblia
a. Background
- Life Cycle and Morphology
- Morphology of Trophozoites
- Clinical Disease
c. Vaccines and Drugs
29. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
30. Granuloma Inguinale
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
31. Hantavirus
a. Background
- Identification of the Agent
- Transmission
- Other Rodent Hantaviruses
- Distribution
- Hantavirus Diseases
- Epidemiology
- Addendum in Proof-Northeastern Connection
- Previously Unknown Pathogens
- Cases Nationwide
- An Immunohistochemistry Approach
- Hantavirus Rapid Diagnostic Test
- ELISA Diagnosis of Hantavirus Pulmonary Syndrome
- IgG ELISA
- IgM Capture ELISA
32. Helicobacter Pylori
a. Background
- Pathogenesis
- Role in Peptic Ulcer Disease
- Role in Gastric Cancer
- Nonulcer Dyspepsia
c. Vaccines and Drugs
- Specific Therapeutic Regimens
- Who Should Be Treated?
- Participants in Controlled Clinical Trials
- Patients with Refractory Peptic Ulcer
- Patients with Refractory NUD
- Patients in High-Risk Groups for Gastric Cancer
a. Background
b. Hepatitis A
c. Hepatitis B
d. Hepatitis C
- Classification
- Transmission of Infection
- Occupational Hazards
- Acute Hepatitis
- Diagnosis of Acute Infection
- Chronic Hepatitis
- HCV and Other Chronic Liver Diseases
- Alcoholic Liver Disease
- Hepatitis B Coinfection
- Cirrhosis and Hepatocellular Carcinoma
- Diagnostic Tests
- Possible Indications for HCV RNA Testing
- Conclusions and Future Direction
- Historical Perspective
- Epidemiology
- HBV-HDV 'Coinfection' vs. 'Superinfection'
- Methods of Detecting HDV
- Prevention
- Background
- Prevalence of the Disease
- Diagnostic Tests
- Epidemiologic Serosurveys
- Serologic Cross-Reactivity
- Vaccines and Drugs
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
35. Human Herpes Virus-6 (HHV-6)
a. Background
- HIV-6 Infections
c. Vaccines and Drugs
36. Influenza Viruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
37. Legionella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
38. Lyme Disease
a. Background
- Clinical Description
- Clinical Case Definition
- Laboratory Criteria for Diagnosis
- Case Classification
c. Vaccines and Drugs
39. Lymphogranuloma Venereum (LGV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
40. Malaria
a. Background
b. Diagnostic Tests
- Potential Diagnositic Problems with Positive Patients from Non-endemic Areas
- Patient
- Laboratory
- Physician
41. Measles (Rubeola)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
42. Meningitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
- Development of Polysaccharide Vaccines
- Quadrivalent Vaccine Development
- Meningococcal A.C.Y. & W-135 Vaccines
- Efficacy of Group C Vaccine
- Efficacy of Group A Vaccine
- Combinations of Group A and C Vaccines
- Group B Efficacy Trials
- Future Direction
a. Background
- Prevalence and Geographic Distribution
- Sources of Human Infection and Transmission
- Light Microscopic Examination of Stool Specimens By Chromotrope Staining
- Stool Concentration Methods
- Chemofluorescent Agents
- Giemsa Staining of Stool Specimens
- Cytologic Diagnosis
- Histologic Examination
- Electron Microscopy
- Examination of Bodily Fluids
- Examination of Tissue Sections
- Immunofluorescence Detection Procedures
- Serology
- Cell Culture
- Approach to Diagnosis
- Evaluation of Patients with Presumptive Intestinal Microsporidiosis
- Evaluation of Patients with Presumptive Ocular Microsporidiosis
44. Mononucleosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
45. Mumps
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
- Efficacy of Vaccination
- Future Issues
a. Background
- Ureaplasma Urealyticum & Mycoplasma Hominis
c. Vaccines and Drugs
47. Papillomaviruses
a. Background
- HPV in Cancer
- Cervical Neoplasm
c. Vaccines and Drugs
- Prevention
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
49. Pneumonia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
50. Polyomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
51. Pseudomonas Aeruginosa
a. Background
- Virulence Factors
c. Vaccines and Drugs
52. Rabies
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
53. Respiratory Syncytial Virus (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
54. RhinoViruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
55. RotaVirus (REOVIRUS)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5 6. Rubella(MEASLES)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
- Developing Countries
- Elimination and Eradication of Measles
- New Developments
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
58. Septicemia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
59. Shigellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
60. Staphylococcus Aureus
a. Background
- The Genus Taphylococcus
c. Vaccines and Drugs
- Prevention
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
- Group A Streptococci
- Group B Streptococci
a. Background
b. Diagnostic Tests
- Biopsy
- Rabbit Infectivity Testing
- Other Diagnostic Modalities
- Syphilis and HIV Infection
- Syphilis As a Cofactor for HIV Transmission
- Basic Science Issues
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
64. Trichomonas Vaginalis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
65. Tuberculosis
a. Background
b. Diagnostic Tests
- Microscopic Characteristics
- Cultural Characteristics
- Detection of Antibodies
- Skin Tests
- MDRTB
66. Vibrio
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
67. West Nile Virus
a. Background
- Clinical Syndromes
c. Vaccines and Drugs
68. Yersina
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review and Market Needs
- Abbott AxSYM
- Abbott IMx/IMx Select
- Anagen AN2000/AuraFlex
- Siemens Immuno 1
- Beckman Coulter Access
- BioChem Pharma/SR1
- BioMerieux/Vitek Vidas
- Biotrol System 7000
- Chiron ACS: Centaur
- Chiron ACS: 180
- Siemens ELISA Processor II/III
- Siemens/Opus/Plus/Magnum
- Siemens Stratus
- J&J Diagnostics Vitros ECi
- J&J Diagnostics/Amersham Amerlite
- Olympus PK310
- Roche Elecsys 1010/2010
- Roche Cobas Core
- Roche ES 300/ 300AL
- Roche ES 22
- Roche ES 33
- Tosoh AIA-1200/ 1200DX/NexIA/ 600
- Wallac/Pharmacia Delfia
1. DNA Probes
a. Technology Overview
b. Amplification Methods
- Polymerase Chain Reaction
- Robotics
- Temperature Cyclers
- PCR Variations
- Immuno-PCR
- QC-PCR
- DAP-PCR
- Ligase Chain Reaction
- Branched DNA
- Q-Beta Replicase
- Nucleic-Acid Sequence-Based
- Strand Displacement Activation
- Self-Sustained Sequence Replicase
3. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- Dot Immunobinding Assays
- Capillary Immunoassays
- Particle-Membrane Capture Immunoassays
- Enzyme Amplification
- Fluorescence Polarization
- Time-Resolved Pulse Fluorescence
- Chemiluminescence
- Bioluminescence
f. Immunoprecipitation
4. Differential Light Scattering
5. Microcomputers and Automation
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. MRI
11. Gel Microdroplets
12. Other
D. Personal Testing
E. Worldwide Business Environment
F. Worldwide Market Structure
G. Worldwide Market Size and Growth
U.S.A.
A. Executive Summary
B. Business Environment
1. Health Care Expenditures
2. Cost Consciousness
3. Reimbursement
4. Industry Consolidation
5. Managed Care
a. HMO
b. PPO
6. Hospitals
7. Admissions
8. Length of Stay
9. Industry Diversification
10. Physician Demographics
11. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
12. Laboratory Regulations
13. FDA Reform
C. Market Structure
1. Centralized Testing
a. Hospitals
b. Commercial/Private Laboratories
c. Blood Banks
1) Community and Regional Centers
2) Plasma Fractionation Centers
2. Decentralized Testing
a. Physician Offices/Group Practices
b. Point of Care Testing
c. Other Decentralized Testing Locations
D. Market Size, Growth and Major Suppliers
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Computers, Software and Automation
D. Auxiliary Products
DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
- Abbott
- Affymetrix
- Applera
- Beckman Coulter
- Becton Dickinson
- Binding Site
- Biomerica
- Biokit
- bioMerieux
- Bio-Rad
- Biotrol
- Biosite
- Biotest
- Caliper Technologies
- Cepheid
- Chemicon
- Daiichi
- DiaSorin
- Diagast
- Diamedix
- Digene
- Eiken
- Enzo Biochem
- Fujirebio
- GenBio
- Gene-Tec
- Hemagen
- Immunetics
- Innogenetics
- Inverness
- J&J
- Meridian
- Nanogen
- Nissui
- Olympus
- Provalis
- Roche
- Saliva Diagnostic
- SeraCare
- Siemens
- Third Wave Technologies
- Thermo Fisher
- Tosho
- Trinity Biotech
- Tropix
- Wampole Labs
- Zenith
- Zeus
LIST OF TABLES
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
Worldwide All Market Segments Laboratories Performing Infectious Disease Tests by Country
Worldwide All Market Segments Total Infectious Disease Test Volume Forecast by Country
Worldwide All Market Segments Total Infectious Disease Diagnostics Market Forecast by Country
Infectious Disease Tests Major Issues and Market Potential For Personal Testing
U.S.A. Summary Table
All Infectious DiseasesTest Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Laboratories Performing Infectious Disease Tests by Market Segment
U.S.A. Hospital Laboratories Performing Infectious Disease Tests by Bed Size
U.S.A. Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume
U.S.A. Physician Office Laboratories Performing Infectious Disease Tests by Practice Size
U.S.A. All Market Segments Infectious Disease Test Volume Forecast
U.S.A. Hospital Laboratories Infectious Disease Test Volume Forecast
U.S.A. Blood Banks Infectious Disease Test Volume Forecast
U.S.A. Physician Office Laboratories Infectious Disease Test Volume Forecast
U.S.A. Commercial/Private Laboratories Infectious Disease Test Volume Forecast
U.S.A. Public Health Laboratories Infectious Disease Test Volume Forecast
U.S.A. All Market Segments Infectious Disease Diagnostics Market Forecast
U.S.A. Hospital Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A. Blood Banks Infectious Disease Diagnostics Market Forecast
U.S.A. Physician Office Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A. Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A. Public Health Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A. HIV or HIVI/hIVII Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HIVAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. BEA Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Candida Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Coronavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. CMV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. EBV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Giardia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Hantavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HBsAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Anti-HBC Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Anti-HBS Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HBcAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Malaria Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Measles Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Mumps Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Parvovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Poliomaviruses Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Pseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rsv Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rheumatoid Arthritis Test Volume And Diagnostics Sales Forecast by Market Segment
U.S.A. Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rubella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Scleroderma Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Staphylococci Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Streptococci Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Trichomonas Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. AIDS Testing Market Diagnostics Sales by Major Supplier
U.S.A. Western Blot Testing Market Diagnostics Sales by Major Supplier
U.S.A. Adenovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Campylobacter Testing Market Diagnostics Sales by Major Supplier
U.S.A. Candida Testing Market Diagnostics Sales by Major Supplier
U.S.A. Chancroid Testing Market Diagnostics Sales by Major Supplier
U.S.A. Chlamydia Testing Market Diagnostics Sales by Major Supplier
U.S.A. CMV Testing Market Diagnostics Sales by Major Supplier
U.S.A. Echovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Enterovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. EBV Testing Market Diagnostics Sales by Major Supplier
U.S.A. Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.S.A. Hepatitis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Hepatitis C Testing Market Diagnostics Sales by Major Supplier
U.S.A. Herpes Testing Market Diagnostics Sales by Major Supplier
U.S.A. Influenza Testing Market Diagnostics Sales by Major Supplier
U.S.A. Legionella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Lyme Disease Testing Market Diagnostics Sales by Major Supplier
U.S.A. Measles Testing Market Diagnostics Sales by Major Supplier
U.S.A. Meningitis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mononucleosis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mumps Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.S.A. Papilloma Testing Market Diagnostics Sales by Major Supplier
U.S.A. Pneumonia Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rabies Testing Market Diagnostics Sales by Major Supplier
U.S.A. RSV Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rheumatoid Arthritis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rotavirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rubella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Salmonella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Septicemia Testing Market Diagnostics Sales by Major Supplier
U.S.A. Shigella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Streptococci Testing Market Diagnostics Sales by Major Supplier
U.S.A. Syphilis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Trichomonas Testing Market Diagnostics Sales by Major Supplier
U.S.A. Tuberculosis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Infectious Disease Diagnostic Testing Instrumentation
Major Systems Estimated Placements and Installed Base
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
Worldwide All Market Segments Laboratories Performing Infectious Disease Tests by Country
Worldwide All Market Segments Total Infectious Disease Test Volume Forecast by Country
Worldwide All Market Segments Total Infectious Disease Diagnostics Market Forecast by Country
Infectious Disease Tests Major Issues and Market Potential For Personal Testing
U.S.A. Summary Table
All Infectious DiseasesTest Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Laboratories Performing Infectious Disease Tests by Market Segment
U.S.A. Hospital Laboratories Performing Infectious Disease Tests by Bed Size
U.S.A. Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume
U.S.A. Physician Office Laboratories Performing Infectious Disease Tests by Practice Size
U.S.A. All Market Segments Infectious Disease Test Volume Forecast
U.S.A. Hospital Laboratories Infectious Disease Test Volume Forecast
U.S.A. Blood Banks Infectious Disease Test Volume Forecast
U.S.A. Physician Office Laboratories Infectious Disease Test Volume Forecast
U.S.A. Commercial/Private Laboratories Infectious Disease Test Volume Forecast
U.S.A. Public Health Laboratories Infectious Disease Test Volume Forecast
U.S.A. All Market Segments Infectious Disease Diagnostics Market Forecast
U.S.A. Hospital Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A. Blood Banks Infectious Disease Diagnostics Market Forecast
U.S.A. Physician Office Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A. Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A. Public Health Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A. HIV or HIVI/hIVII Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HIVAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. BEA Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Candida Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Coronavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. CMV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. EBV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Giardia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Hantavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HBsAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Anti-HBC Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Anti-HBS Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HBcAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Malaria Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Measles Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Mumps Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Parvovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Poliomaviruses Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Pseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rsv Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rheumatoid Arthritis Test Volume And Diagnostics Sales Forecast by Market Segment
U.S.A. Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rubella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Scleroderma Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Staphylococci Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Streptococci Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Trichomonas Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. AIDS Testing Market Diagnostics Sales by Major Supplier
U.S.A. Western Blot Testing Market Diagnostics Sales by Major Supplier
U.S.A. Adenovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Campylobacter Testing Market Diagnostics Sales by Major Supplier
U.S.A. Candida Testing Market Diagnostics Sales by Major Supplier
U.S.A. Chancroid Testing Market Diagnostics Sales by Major Supplier
U.S.A. Chlamydia Testing Market Diagnostics Sales by Major Supplier
U.S.A. CMV Testing Market Diagnostics Sales by Major Supplier
U.S.A. Echovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Enterovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. EBV Testing Market Diagnostics Sales by Major Supplier
U.S.A. Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.S.A. Hepatitis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Hepatitis C Testing Market Diagnostics Sales by Major Supplier
U.S.A. Herpes Testing Market Diagnostics Sales by Major Supplier
U.S.A. Influenza Testing Market Diagnostics Sales by Major Supplier
U.S.A. Legionella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Lyme Disease Testing Market Diagnostics Sales by Major Supplier
U.S.A. Measles Testing Market Diagnostics Sales by Major Supplier
U.S.A. Meningitis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mononucleosis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mumps Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.S.A. Papilloma Testing Market Diagnostics Sales by Major Supplier
U.S.A. Pneumonia Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rabies Testing Market Diagnostics Sales by Major Supplier
U.S.A. RSV Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rheumatoid Arthritis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rotavirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rubella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Salmonella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Septicemia Testing Market Diagnostics Sales by Major Supplier
U.S.A. Shigella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Streptococci Testing Market Diagnostics Sales by Major Supplier
U.S.A. Syphilis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Trichomonas Testing Market Diagnostics Sales by Major Supplier
U.S.A. Tuberculosis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Infectious Disease Diagnostic Testing Instrumentation
Major Systems Estimated Placements and Installed Base